Trials / Active Not Recruiting
Active Not RecruitingNCT06332014
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
A Phase 4 Single Arm Open Label Study for the Efficacy and Safety of Prolia in Treatment of Male Subjects With Osteoporosis in Mainland China
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Amgen · Industry
- Sex
- Male
- Age
- 30 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the efficacy of Prolia on lumbar spine BMD at 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prolia | Partcipants will receive subcutaneous (SC) injections of Prolia Q6M. |
Timeline
- Start date
- 2024-08-06
- Primary completion
- 2027-01-23
- Completion
- 2027-01-23
- First posted
- 2024-03-26
- Last updated
- 2026-02-12
Locations
16 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06332014. Inclusion in this directory is not an endorsement.